CN105073995A - 增强的转基因表达和加工 - Google Patents

增强的转基因表达和加工 Download PDF

Info

Publication number
CN105073995A
CN105073995A CN201480010305.9A CN201480010305A CN105073995A CN 105073995 A CN105073995 A CN 105073995A CN 201480010305 A CN201480010305 A CN 201480010305A CN 105073995 A CN105073995 A CN 105073995A
Authority
CN
China
Prior art keywords
mar
nucleic acid
expression
protein
tep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480010305.9A
Other languages
English (en)
Chinese (zh)
Inventor
V·勒富尔
N·梅尔莫
A·雷加梅
M·巴赛特
D·莱伊
N·哈拉奇
K·科斯特拉科
P-A·吉拉
D·卡拉布列兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Selexis SA
Original Assignee
Selexis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selexis SA filed Critical Selexis SA
Priority to CN202510831703.7A priority Critical patent/CN120718957A/zh
Publication of CN105073995A publication Critical patent/CN105073995A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480010305.9A 2013-02-01 2014-02-01 增强的转基因表达和加工 Pending CN105073995A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202510831703.7A CN120718957A (zh) 2013-02-01 2014-02-01 增强的转基因表达和加工

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361759802P 2013-02-01 2013-02-01
US61/759,802 2013-02-01
US201361800244P 2013-03-15 2013-03-15
US61/800,244 2013-03-15
US201361806634P 2013-03-29 2013-03-29
US61/806,634 2013-03-29
PCT/IB2014/000100 WO2014118619A2 (en) 2013-02-01 2014-02-01 Enhanced transgene expression and processing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202510831703.7A Division CN120718957A (zh) 2013-02-01 2014-02-01 增强的转基因表达和加工

Publications (1)

Publication Number Publication Date
CN105073995A true CN105073995A (zh) 2015-11-18

Family

ID=50239688

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202510831703.7A Pending CN120718957A (zh) 2013-02-01 2014-02-01 增强的转基因表达和加工
CN201480010305.9A Pending CN105073995A (zh) 2013-02-01 2014-02-01 增强的转基因表达和加工

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202510831703.7A Pending CN120718957A (zh) 2013-02-01 2014-02-01 增强的转基因表达和加工

Country Status (20)

Country Link
US (1) US11898154B2 (enExample)
EP (2) EP3536797B1 (enExample)
JP (1) JP6563816B2 (enExample)
KR (1) KR102235603B1 (enExample)
CN (2) CN120718957A (enExample)
AU (2) AU2014210856B2 (enExample)
CA (1) CA2898878C (enExample)
DK (2) DK2951309T3 (enExample)
ES (2) ES2717175T3 (enExample)
FI (1) FI3536797T3 (enExample)
HU (2) HUE061494T2 (enExample)
IL (1) IL240198B (enExample)
LT (1) LT2951309T (enExample)
PL (2) PL3536797T3 (enExample)
PT (2) PT3536797T (enExample)
RU (1) RU2711505C9 (enExample)
SG (2) SG10201803758XA (enExample)
SI (1) SI2951309T1 (enExample)
WO (1) WO2014118619A2 (enExample)
ZA (1) ZA201506419B (enExample)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108504692A (zh) * 2018-03-26 2018-09-07 安徽大学 一种基因敲除cho细胞株的构建方法及其在治疗性重组蛋白表达中的应用
CN109072257A (zh) * 2016-03-15 2018-12-21 马克思-德布鲁克-分子医学中心亥姆霍兹联合会 增强的睡美人转座子、试剂盒和转座方法
CN109071601A (zh) * 2016-03-14 2018-12-21 安吉拉·安娜·梅西纳 药学活性肽化合物，其制备方法和用途
CN109312360A (zh) * 2016-03-15 2019-02-05 马克思-德布鲁克-分子医学中心亥姆霍兹联合会 用于原代细胞的基于转座子的转染系统
CN109415748A (zh) * 2016-05-03 2019-03-01 隆扎有限公司 用于蛋白生产的脂质代谢的调节
CN109576269A (zh) * 2014-04-01 2019-04-05 三生国健药业（上海）股份有限公司 一种新型的含mar核心片段的动物细胞表达载体
CN109790539A (zh) * 2016-10-03 2019-05-21 第一三共株式会社 Hspa5基因的启动子
CN111465697A (zh) * 2017-09-29 2020-07-28 贝特基因 用于预防或治疗心力衰竭的药物组合物
CN111500629A (zh) * 2020-04-17 2020-08-07 安徽中盛溯源生物科技有限公司 一种高表达层粘连蛋白-511变体的方法及其应用
CN113166767A (zh) * 2018-09-05 2021-07-23 马克思-德布鲁克-分子医学中心亥姆霍兹联合会 用于工程合成顺式调控dna的方法
CN113557297A (zh) * 2019-02-18 2021-10-26 帕多瓦大学 具有抗肿瘤活性的肽
CN113881703A (zh) * 2021-10-11 2022-01-04 中国人民解放军军事科学院军事医学研究院 一种提高cho细胞同源重组效率的方法及其相关产品和应用
CN114958914A (zh) * 2022-06-06 2022-08-30 新乡医学院 一种高效人类及哺乳动物细胞附着体表达载体、构建方法和应用
CN116440269A (zh) * 2022-01-10 2023-07-18 华中农业大学 Slc35a1基因作为靶点在防治猪流行性腹泻病中的应用

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105154473B (zh) * 2015-09-30 2019-03-01 上海细胞治疗研究院 一种高效安全的转座子整合系统及其用途
JP2017070224A (ja) * 2015-10-06 2017-04-13 国立大学法人 岡山大学 遺伝子発現用カセット及びその産生物
JP6871679B2 (ja) * 2016-03-23 2021-05-12 国立大学法人 岡山大学 遺伝子発現用カセット及びその産生物
US20180265894A1 (en) * 2015-10-06 2018-09-20 National University Corporation Okayama University Gene Expression Cassette And Product Thereof
JP7370702B2 (ja) 2015-12-24 2023-10-30 セレクシス エス．エー． タンパク質製造用の改善された真核細胞およびそれらの作製方法
US11278570B2 (en) 2016-12-16 2022-03-22 B-Mogen Biotechnologies, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
JP7275043B2 (ja) 2016-12-16 2023-05-17 ビー－モーゲン・バイオテクノロジーズ，インコーポレーテッド 増大したｈＡＴファミリートランスポゾン媒介遺伝子導入ならびに関連する組成物、システムおよび方法
WO2018224162A1 (en) * 2017-06-09 2018-12-13 Biontech Rna Pharmaceuticals Gmbh Methods for characterizing loss of antigen presentation
CN109929839B (zh) * 2017-12-18 2021-02-12 华东师范大学 拆分型单碱基基因编辑系统及其应用
EP3794128A1 (en) * 2018-05-18 2021-03-24 Sorbonne Universite Molecular tools and methods for transgene integration and their transposition dependent expression
WO2019246486A2 (en) 2018-06-21 2019-12-26 B-Mogen Biotechnologies, Inc. ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
RU2686102C1 (ru) * 2018-08-07 2019-04-24 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Рекомбинантный вектор для создания плазмидных генетических конструкций, обладающих повышенной длительностью экспрессии целевых генов
US20210380661A1 (en) * 2018-10-16 2021-12-09 Texas Tech University System Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes
US20230193341A1 (en) 2018-10-24 2023-06-22 Selexis Sa Expression systems, recombinant cells and uses thereof
EP3902910A1 (en) * 2018-12-24 2021-11-03 Selexis S.A. Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells
WO2020152532A1 (en) 2019-01-23 2020-07-30 Enzyvant Therapeutics Gmbh Method of ameliorating a pro-inflammatory immunophenotype in farber disease subjects by repeated administration of a recombinant human acid ceramidase
TWI818166B (zh) * 2019-03-27 2023-10-11 美商菲尼克斯組織修復公司 用於生產膠原蛋白7組合物之系統及方法
CN110006866B (zh) * 2019-04-16 2022-04-22 杭州迈尔德生物科技有限公司 一种阿片类活性物质的通用检测方法及其检测试剂盒
WO2020228721A1 (en) * 2019-05-13 2020-11-19 Lin Mei Chun Method and kit for monitoring cancer
CN114514324A (zh) * 2019-10-10 2022-05-17 加利福尼亚州立大学董事会 稳定哺乳动物细胞的方法
IL270306A (en) 2019-10-30 2021-05-31 Yeda Res & Dev Prevention and treatment of pre-myeloid and myeloid malignancies
CN112813099A (zh) * 2019-11-15 2021-05-18 上海细胞治疗集团有限公司 一种在活化的t细胞中具有高活性的启动子
CN110863008B (zh) * 2019-11-22 2020-10-16 昆明学院 Mar序列调控弱启动子构建高效表达载体的方法
CN115151558A (zh) 2019-12-24 2022-10-04 思兰克斯有限公司 哺乳动物序列中的靶向整合增强基因表达
BR112022016617A2 (pt) * 2020-02-19 2022-11-22 Wuxi Biologics Ireland Ltd Ácido nucleico, vetor, vetor de transposon, sistema de expressão, ácido nucleico isolado, método para gerar uma célula, célula, método de expressão de uma proteína, proteína, composiçao farmacêutica, sistema de expressão, linhagem celular
US20230242936A1 (en) * 2020-05-14 2023-08-03 Seattle Children's Hospital (dba Seattle Children's Research Institute) Dual promoter systems
US12173304B2 (en) * 2020-07-08 2024-12-24 Neuracle Genetics Inc. Intron fragments
CN115896227A (zh) * 2022-12-20 2023-04-04 西北农林科技大学 一种鉴定外源基因整合位点以增强转基因表达的方法
GB202305637D0 (en) 2023-04-17 2023-05-31 Macomics Ltd Transposons, vectors and genetically engineered cells

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235011A1 (en) * 2002-06-26 2004-11-25 Cooper Richard K. Production of multimeric proteins
US20100105140A1 (en) * 2008-07-16 2010-04-29 Fahrenkrug Scott C Plaice dna transposon system
WO2010118360A1 (en) * 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production of proteins using transposon-based vectors
WO2011033375A2 (en) * 2009-09-18 2011-03-24 Selexis S.A. Products and methods for enhanced transgene expression and processing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731178A (en) 1990-03-21 1998-03-24 Behringwerke Aktiengesellschaft Attachment-elements for stimulation of eukaryotic expression systems
JP3656277B2 (ja) * 1995-05-17 2005-06-08 味の素株式会社 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法
CA2435972C (en) 2001-01-26 2011-09-13 University Of Lausanne Matrix attachment regions and methods for use thereof
WO2004065581A2 (en) * 2003-01-15 2004-08-05 Discovery Genomics, Inc. Transposon-insulator element delivery systems
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
RU2375450C2 (ru) 2003-10-24 2009-12-10 Селексис С.А. Днк, повышающая продуцирование белка, и ее применение
ES2292271B1 (es) * 2004-05-20 2009-02-16 Proyecto De Biomedicina Cima, S.L. Un vector hibrido adenovirus-alfavirus para la administracion eficaz y expresion de genes terapeuticos en celulas tumorales.
CA2611465A1 (en) 2005-06-10 2007-02-22 Genentech, Inc. Improving antibody expression using vectors containing insulator elements
EP3156414B1 (en) * 2007-09-26 2019-12-04 Intrexon Corporation Synthetic 5'utrs, expression vectors, and methods for increasing transgene expression
US20090247609A1 (en) 2007-12-20 2009-10-01 Hitto Kaufmann Sm-protein based secretion engineering

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235011A1 (en) * 2002-06-26 2004-11-25 Cooper Richard K. Production of multimeric proteins
US20100105140A1 (en) * 2008-07-16 2010-04-29 Fahrenkrug Scott C Plaice dna transposon system
WO2010118360A1 (en) * 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production of proteins using transposon-based vectors
WO2011033375A2 (en) * 2009-09-18 2011-03-24 Selexis S.A. Products and methods for enhanced transgene expression and processing

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109576269B (zh) * 2014-04-01 2020-08-28 三生国健药业（上海）股份有限公司 一种含mar核心片段的动物细胞表达载体
CN109576269A (zh) * 2014-04-01 2019-04-05 三生国健药业（上海）股份有限公司 一种新型的含mar核心片段的动物细胞表达载体
CN109071601A (zh) * 2016-03-14 2018-12-21 安吉拉·安娜·梅西纳 药学活性肽化合物，其制备方法和用途
CN109072257A (zh) * 2016-03-15 2018-12-21 马克思-德布鲁克-分子医学中心亥姆霍兹联合会 增强的睡美人转座子、试剂盒和转座方法
CN109312360A (zh) * 2016-03-15 2019-02-05 马克思-德布鲁克-分子医学中心亥姆霍兹联合会 用于原代细胞的基于转座子的转染系统
CN109312360B (zh) * 2016-03-15 2022-10-28 马克思-德布鲁克-分子医学中心亥姆霍兹联合会 用于原代细胞的基于转座子的转染系统
CN109415748A (zh) * 2016-05-03 2019-03-01 隆扎有限公司 用于蛋白生产的脂质代谢的调节
US11555204B2 (en) 2016-10-03 2023-01-17 Daiichi Sankyo Company, Limited Promoter of Hspa5 gene
CN109790539A (zh) * 2016-10-03 2019-05-21 第一三共株式会社 Hspa5基因的启动子
TWI812596B (zh) * 2016-10-03 2023-08-21 日商第一三共股份有限公司 Hspa5基因的啓動子
CN111465697A (zh) * 2017-09-29 2020-07-28 贝特基因 用于预防或治疗心力衰竭的药物组合物
CN111465697B (zh) * 2017-09-29 2023-10-13 贝特基因 用于预防或治疗心力衰竭的药物组合物
CN108504692B (zh) * 2018-03-26 2021-07-23 安徽大学 一种基因敲除cho细胞株的构建方法及其在治疗性重组蛋白表达中的应用
CN108504692A (zh) * 2018-03-26 2018-09-07 安徽大学 一种基因敲除cho细胞株的构建方法及其在治疗性重组蛋白表达中的应用
CN113166767A (zh) * 2018-09-05 2021-07-23 马克思-德布鲁克-分子医学中心亥姆霍兹联合会 用于工程合成顺式调控dna的方法
CN113557297A (zh) * 2019-02-18 2021-10-26 帕多瓦大学 具有抗肿瘤活性的肽
CN111500629B (zh) * 2020-04-17 2021-11-19 安徽中盛溯源生物科技有限公司 一种高表达层粘连蛋白-511变体的方法及其应用
CN111500629A (zh) * 2020-04-17 2020-08-07 安徽中盛溯源生物科技有限公司 一种高表达层粘连蛋白-511变体的方法及其应用
CN113881703B (zh) * 2021-10-11 2022-06-21 中国人民解放军军事科学院军事医学研究院 一种提高cho细胞同源重组效率的方法及其相关产品和应用
CN113881703A (zh) * 2021-10-11 2022-01-04 中国人民解放军军事科学院军事医学研究院 一种提高cho细胞同源重组效率的方法及其相关产品和应用
CN116440269A (zh) * 2022-01-10 2023-07-18 华中农业大学 Slc35a1基因作为靶点在防治猪流行性腹泻病中的应用
CN116440269B (zh) * 2022-01-10 2024-02-09 华中农业大学 Slc35a1基因作为靶点在防治猪流行性腹泻病中的应用
CN114958914A (zh) * 2022-06-06 2022-08-30 新乡医学院 一种高效人类及哺乳动物细胞附着体表达载体、构建方法和应用
CN114958914B (zh) * 2022-06-06 2023-09-26 新乡医学院 一种人类及哺乳动物细胞附着体表达载体、构建方法和应用

Also Published As

Publication number Publication date
RU2015127667A (ru) 2017-03-06
FI3536797T3 (fi) 2023-03-23
IL240198A0 (en) 2015-09-24
RU2711505C9 (ru) 2020-08-12
CA2898878A1 (en) 2014-08-07
ZA201506419B (en) 2017-02-22
RU2711505C2 (ru) 2020-01-17
PT2951309T (pt) 2019-04-03
US20150361451A1 (en) 2015-12-17
JP6563816B2 (ja) 2019-08-21
EP3536797B1 (en) 2023-01-04
EP2951309B1 (en) 2019-01-30
DK3536797T5 (da) 2024-09-02
CA2898878C (en) 2020-04-28
ES2717175T3 (es) 2019-06-19
HUE043103T2 (hu) 2019-08-28
US11898154B2 (en) 2024-02-13
EP2951309A2 (en) 2015-12-09
AU2019250224B2 (en) 2022-05-12
AU2019250224A1 (en) 2019-11-07
KR20150123803A (ko) 2015-11-04
EP3536797A1 (en) 2019-09-11
AU2014210856A1 (en) 2015-07-30
ES2940433T3 (es) 2023-05-08
JP2016504922A (ja) 2016-02-18
WO2014118619A3 (en) 2014-10-30
PL2951309T3 (pl) 2019-06-28
PT3536797T (pt) 2023-03-15
SG10201803758XA (en) 2018-06-28
DK2951309T3 (en) 2019-04-23
KR102235603B1 (ko) 2021-04-05
CN120718957A (zh) 2025-09-30
DK3536797T3 (da) 2023-04-03
IL240198B (en) 2019-10-31
WO2014118619A2 (en) 2014-08-07
HK1216323A1 (en) 2016-11-04
HUE061494T2 (hu) 2023-07-28
LT2951309T (lt) 2019-03-25
SI2951309T1 (sl) 2019-04-30
AU2014210856B2 (en) 2019-10-24
PL3536797T3 (pl) 2023-09-11
SG11201505487UA (en) 2015-08-28

Similar Documents

Publication Publication Date Title
JP6563816B2 (ja) 増強された導入遺伝子発現およびプロセシング
AU2016304795B2 (en) Engineered CRISPR-Cas9 compositions and methods of use
US20120231449A1 (en) Products and methods for enhanced transgene expression and processing
CA2934411C (en) Novel eukaryotic cells and methods for recombinantly expressing a product of interest
JP2016540518A (ja) 新規真核細胞および目的の生成物を組換え発現させるための方法
JP2018537986A (ja) タンパク質製造用の改善された真核細胞およびそれらの作製方法
US9551009B2 (en) Transcription unit and use thereof in expression vectors
WO2013006142A1 (en) A novel process and reagent for rapid genetic alterations in eukaryotic cells
US20210403924A1 (en) Method for selecting cells based on CRISPR/Cas-mediated integration of a detectable tag to a target protein
WO2016054616A1 (en) Methods and compositions for use of non-coding rna in cell culturing and selection
EP3901266A1 (en) Super-enhancers for recombinant gene expression in cho cells
RU2808756C1 (ru) Улучшенные экспрессия и процессинг трансгена
JP2025524994A (ja) Ｃｄ３９バリアントの産生の改善
HK40007175B (en) Enhanced transgene expression and processing
HK40007175A (en) Enhanced transgene expression and processing
HK1216323B (en) Enhanced transgene expression and processing
US9512230B2 (en) Transcription units and the use thereof in expression vectors
Kim et al. Limitations of the plasmid-based Cas9-zinc finger fusion system for homology-directed knock-in in Chinese hamster ovary cells

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20151118